ArticleOxford open digital health2026
Lessons from using SALAMA (DIGIT HCM-health campaign management platform) to implement and optimize seasonal malaria chemoprevention in Nampula, Mozambique.
Article in Oxford open digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Characteristics and Outcomes of Hospitalized Malaria Patients in Rural Madagascar.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mozambique has the fifth highest malaria burden globally, with children under five most affected. To reduce this impact, Mozambique adopted seasonal malaria chemoprevention as a national strategy. In 2024, the National Malaria Control Program, in collaboration with Malaria Consortium and eGovernments Foundation, transitioned from paper-based to digital data collection using the DIGIT Health Campaign Management platform. We describe the digitalization process from planning to implementation and document the lessons. A cascade training and real-time dashboards facilitated data monitoring, stock tracking and supervision. Key results included improved sulfadoxine-pyrimethamine plus amodiaquine administration, enhanced data use for daily decision-making and early identification of outliers. For example, in Moma district sulfadoxine-pyrimethamine plus amodiaquine wastage exceeded 10% on the first day-unusual wastage rates are defined as >5%-prompting immediate targeted supervision which reduced wastage on subsequent days. Challenges including device power constraints, internet connectivity and local technical capacity, which were addressed through training and on-the-ground technical support. The digital approach improved campaign efficiency, transparency, responsiveness and supervision quality. Administrative coverage rates (75-109%) were more consistent with survey-based household coverage (~74%) in the digital campaign than the paper-based campaign which were 93-105% and ~79%, respectively. Importantly, the digital approach allowed for the visualization of the proportion of first-day doses recorded digitally in real time and the direct observation of therapy adherence, an important indicator of seasonal malaria chemoprevention campaign quality. This experience highlights how digital innovations, when well-coordinated and adapted to local contexts, can enhance malaria prevention and provide a case study to inform the scaling digital health interventions across public health programmes in Mozambique.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.